	Primary hepatic follicular dendritic cell sarcoma: A case study and literature review. J Int Med Res Zhu J, Liang Y, Zhang L, Li B, Zheng D, Wang H. PMID: 41454748 [PubMed - indexed for MEDLINE]
	A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using Organoids. Cancer Med Liu Y, Tao L, Shen Z, Zheng J, Wang Y, Chen M, Xie Y, Chen H, Cai J, Pan H, Li S, Jin R, Xu J, Liang X. PMID: 41454619 [PubMed - indexed for MEDLINE]
	Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. Ann Med Song R, Li M, Tang S, Zhang G. PMID: 41454610 [PubMed - indexed for MEDLINE]
	Nanovaccines in hepatocellular carcinoma: a new frontier in cancer immunotherapy. Med Oncol Usmani A, Siddiqui MA, Mishra A, Almoselhy RIM, Shoaib A, Gobinath M, Ansari MN. PMID: 41452547 [PubMed - indexed for MEDLINE]
	Ethical challenges and governance of artificial intelligence in hepatocellular carcinoma management : Wan DL et al. Ethical considerations in AI for hepatocellular carcinoma. Med Oncol Wan DL, Lin SZ. PMID: 41452505 [PubMed - indexed for MEDLINE]
	Therapeutic potential of natural triterpenoids in liver cancer. Med Oncol Niu C, Zhang J, Okolo Iii PI. PMID: 41452426 [PubMed - indexed for MEDLINE]
	Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study. Liver Int Kim JS, Wong J, Chen SC, Tai D, Yang H, Kim Y, Kang B, Kim I, Kim H, An C, Jang SJ, Kudo M, Lim HY, Kim C, Yau T, Chon HJ. PMID: 41451780 [PubMed - indexed for MEDLINE]
	Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden. Front Immunol Guan MC, Li N, Ding Q, Sun D, Li H, Yang M, Hong L, Zhu H. PMID: 41451207 [PubMed - indexed for MEDLINE]
	Circular RNA in hepatocellular carcinoma: emerging therapeutic strategies. Front Immunol Jazbec G, Re. PMID: 41445747 [PubMed - indexed for MEDLINE]
	Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Curr Oncol Minamiguchi K, Irizato M, Nakano R, Kunichika H, Tachiiri T, Taiji R, Tsuji Y, Yasuda S, Yoshiji H, Sho M, Tanaka T. PMID: 41440222 [PubMed - indexed for MEDLINE]
	Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma. Curr Oncol Ye G, Zhang H, Feng Q, Xiao J, Wang J, Liu J. PMID: 41440201 [PubMed - indexed for MEDLINE]
	Hepatoblastoma Cell Lines: Past, Present and Future. Cells Prochownik EV, Henchy CM, Wang H. PMID: 41440033 [PubMed - indexed for MEDLINE]
	Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments. Front Immunol Yadav DK, Yadav RK, Singh A, Huang Y, Bao D, Yang Z, Huang H, Jiang Y, Wang P, Lin S, Hua Y, Hu Y. PMID: 41438763 [PubMed - indexed for MEDLINE]
	Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma. Front Immunol Chen PJ, Devkota S, Shiao S, Hendifar A, Yang JD. PMID: 41438742 [PubMed - indexed for MEDLINE]
	Antitumor Effects of Tumor-Derived Exosomes in Murine Hepatocellular Carcinoma Models. Iran J Immunol Xu W, Fan L. PMID: 41432120 [PubMed - indexed for MEDLINE]
	Long-Term Prognostic Significance of TACE-Induced Complete Pathological Response in Patients with Hepatocellular Carcinoma Who Have Undergone Liver Transplantation. Ann Transplant Jeong IJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang WH, Yoon YI, Lee SG. PMID: 41431134 [PubMed - indexed for MEDLINE]
	Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. Medicine (Baltimore) Yang J, Xu Q, Wu S. PMID: 41431101 [PubMed - indexed for MEDLINE]
	Causal role of immunophenotypes in hepatocellular carcinoma: A Mendelian randomization study. Medicine (Baltimore) Ou D, Huo J. PMID: 41431046 [PubMed - indexed for MEDLINE]
	An integrated chemokine-based machine learning model predicts prognosis and guides immunotherapy in hepatocellular carcinoma. Medicine (Baltimore) Zhou J, Liu J, Wei X, Liu C, Gu H. PMID: 41431005 [PubMed - indexed for MEDLINE]
	Deep learning for hepatocellular carcinoma segmentation in MRI: A systematic review of models, performance, and challenges. Medicine (Baltimore) Elhaie M, Koozari A, Arjmandi M, Najafizade N. PMID: 41430967 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74766

Page 1 of 3739



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy